纳米材料
表型
脾脏
机制(生物学)
细胞生物学
化学
纳米技术
免疫学
生物物理学
生物
材料科学
生物化学
基因
认识论
哲学
作者
Kim Tsoi,Sonya A. MacParland,Xue Zhong,Vinzent N. Spetzler,Juan Echeverri,Ben Ouyang,Saleh Fadel,Edward A. Sykes,Nicolás Goldaracena,J. Moritz Kaths,John B. Conneely,Benjamin A. Alman,Markus Selzner,Mario Ostrowski,Oyedele Adeyi,Anton Zilman,Ian D. McGilvray,Warren C. W. Chan
出处
期刊:Nature Materials
[Springer Nature]
日期:2016-08-15
卷期号:15 (11): 1212-1221
被引量:703
摘要
The liver and spleen are major biological barriers to translating nanomedicines because they sequester the majority of administered nanomaterials and prevent delivery to diseased tissue. Here we examined the blood clearance mechanism of administered hard nanomaterials in relation to blood flow dynamics, organ microarchitecture and cellular phenotype. We found that nanomaterial velocity reduces 1,000-fold as they enter and traverse the liver, leading to 7.5 times more nanomaterial interaction with hepatic cells relative to peripheral cells. In the liver, Kupffer cells (84.8 ± 6.4%), hepatic B cells (81.5 ± 9.3%) and liver sinusoidal endothelial cells (64.6 ± 13.7%) interacted with administered PEGylated quantum dots, but splenic macrophages took up less material (25.4 ± 10.1%) due to differences in phenotype. The uptake patterns were similar for two other nanomaterial types and five different surface chemistries. Potential new strategies to overcome off-target nanomaterial accumulation may involve manipulating intra-organ flow dynamics and modulating the cellular phenotype to alter hepatic cell interactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI